Vecuronium Bromide Injection, Powder, Lyophilized, For Solution
Product Images NDC 71288-744

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Vecuronium Bromide (NDC 71288-744). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Vecuronium Bromide for Injection, 10 mg Vial Carton)

Packaging label for Vecuronium Bromide 10 mg injection, powder, lyophilized for solution, supplied by Meitheal Pharmaceuticals Inc. The label includes warnings about respiratory arrest and dosage preparation, stating it is for intravenous use only. The carton design shows the proprietary name, dosage strength, and NDC number, along with storage instructions and barcode.*

FDA Label Image

Principal Display Panel (Vecuronium Bromide for Injection, 10 mg Vial Container Label)

Label for Vecuronium Bromide for Injection, 10 mg strength, lyophilized powder for intravenous solution by Meitheal Pharmaceuticals Inc. The label specifies single-dose vial usage, contains warnings about its paralyzing agent effects, and instructions for reconstitution with sterile water or compatible intravenous solution. Includes NDC 71288-744-10 barcode and lot/expiration date areas.*

FDA Label Image

Principal Display Panel (Vecuronium Bromide for Injection, 20 mg Vial Carton)

Packaging label for Vecuronium Bromide 20 mg injection, powder, lyophilized, for solution. The label indicates it is for intravenous use, sterile, and contains 10 single-dose vials. It includes a warning for paralyzing agent and is labeled for prescription use by Meitheal Pharmaceuticals Inc.*

FDA Label Image

Principal Display Panel (Vecuronium Bromide for Injection, 20 mg Vial Container Label)

Label for Vecuronium Bromide for Injection, 20 mg strength, powder for solution injection, intravenous route. The label indicates the product is a single-dose vial, sterile, and for intravenous use only. It includes warnings about paralysis risk and alcohol use, dosage instructions, and the labeler as Meitheal Pharmaceuticals Inc., Madison, Wisconsin, USA.*

FDA Label Image

Vecuronium Bromide Structural Formula (Vecuronium Structure)

Chemical structure of Vecuronium Bromide depicting its molecular framework with multiple cyclic rings, methyl groups, acetyl groups, and a bromide ion, consistent with its designation as the active ingredient in the injection powder formulation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.